• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
Generic Name:  physostigmine salicylatephysostigmine salicylate
Date Designated:  01/16/1985
Orphan Designation:  Treatment of Friedreich's and other inherited ataxias.
Orphan Designation Status:  Designated/Withdrawn
FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication
Forest Pharmaceuticals.3-.3-.30 6
150 East 58th Street
New York, New York 10155
United States

The sponsor address listed is the last reported by the sponsor to OOPD.
*Exclusivity Protected Indications are shown for approvals from Jan. 1, 2013, to the present.